Director Matthew K Fust sold $535K of Atara Biotherapeutics, Inc.

Sold$535,301

$43.57Price

12,286Shares

−38%Stake

What ATRA did after the filing

Prices for ATRA after this filing aren't in yet.

Traded Mon, May 14. Filed Wed, May 16, 4:40 PM ET, after the close. Not investment advice.